DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
157 hedge funds and large institutions have $871M invested in DIPLOMAT PHARMACY, INC. in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 65 increasing their positions, 51 reducing their positions, and 38 closing their positions.
276% more call options, than puts
Call options by funds: $7.78M | Put options by funds: $2.07M
27% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 51
11% less funds holding
Funds holding: 177 → 157 (-20)
30% less capital invested
Capital invested by funds: $1.24B → $871M (-$366M)
47% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 38
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$44.8M |
| 2 |
DM
Deerfield Management
New York
|
+$25.2M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$15.6M |
| 4 |
Bank of New York Mellon
New York
|
+$14M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$39.9M |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$24M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$15.7M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11.9M |
| 5 |
Man Group
London,
United Kingdom
|
-$9.39M |
DPLO Hedge Fund Activity: Q4 2018 in Review
157 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2018, worth a combined $871M — down 30% from $1.24B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of DPLO and 20 opened new positions — a net loss of 18 holders — while 51 trimmed existing stakes and 65 added.
The largest buyer was Janus Henderson Group, adding an estimated $44.8M. The largest seller was Frontier Capital Management, cutting an estimated $39.9M.
- 157 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2018, down from 177 in Q3 2018.
- Funds reported $871M of DIPLOMAT PHARMACY, INC. stock for Q4 2018, down 30% quarter-over-quarter.
- 20 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2018 and 38 closed out, a net change of -18 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2018 was Janus Henderson Group, an estimated $44.8M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q4 2018 was Frontier Capital Management, an estimated $39.9M sold.
Based on aggregated 13F filings for Q4 2018.